Marketing-authorisation holder · United States
Knoa Pharma
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADHANSIA XR25mg | 35mg | 45mg | 55mg | 70mg | 85mg · Capsule, extended release | Methylphenidate | United States | Not marketed | 2019 |
| BUTRANS10mcg/hr | 15mcg/hr | 20mcg/hr | 5mcg/hr | 7.5mcg/hr · Film, extended release | Buprenorphine | United States | Marketed | 2010 |
| MS CONTIN100mg | 15mg | 200mg | 30mg | 60mg · Tablet, extended release | Morphine | United States | Marketed | 1987 |
| NALMEFENE HYDROCHLORIDE0.1mg base/ml (eq 0.1mg base/ml) | 2mg base/2ml (eq 1mg base/ml) | 2mg base/2ml (eq 1mgbase/ml) · Solution | Nalmefene | United States | Marketed | 2022 |
| OXYCONTIN10mg | 15mg | 20mg | 30mg | 40mg | 60mg | 80mg · Tablet, extended release | Oxycodone | United States | Marketed | 2010 |
| ZURNAI (AUTOINJECTOR)1.5mg base/0.5ml (eq 1.5mg base/0.5ml) · Solution | Nalmefene | United States | Marketed | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past |
|---|